Key facts
- It has raised $4.7M across 1 recorded rounds; the latest was Seed Round ($4.7M) in Dec 2025.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Rare Air Health
Funding rounds
1 roundsAbout Rare Air Health
Developer of a precision pulmonary drug delivery platform designed to bring aerosolized gene therapy to the world. The company's platform targets the pulmonary system and increases the speed and efficacy of pulmonary gene therapies, enabling medical professionals to provide more effective and localized treatment at lower dosages compared to systemic routes such as injectables.
- Sector
- Healthcare
- HQ
- Corvallis, OR, United States
- Founded
- 2021
- Employees
- 3
- Website
- rareair.health/
- Ownership
- Privately Held (backing)
Rare Air Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rare Air Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rare Air Health in its N-PORT filings yet. We sweep new filings monthly.